Government Exclusion and Anti-Kickback Controls in the New Era of Copay Assistance
Hosted by World Congress
Jason Zemcik, VP Patient Affordability and Practice Lead, TrialCard
Recent evolution in copay assistance program designs, combined with policy developments around government-sponsored healthcare programs, has brought about a heightened focus on ensuring effective government exclusion and anti-kickback controls. As pharmaceutical manufacturers shift to alternate delivery and reimbursement models to address multiple payer tactics, it is imperative to maintain effective controls to prevent government-insured patients from accessing program benefits in accordance with the Federal Anti-Kickback Statute the Office of the Inspector General (OIG) guidance around coupon programs.
- Learn how to incorporate controls across multiple points in the patient’s interaction with your program to create layers of protection
- Discuss risks brought on by alternate program designs and how to mitigate them while still accomplishing program objectives
- Examine how recently-enacted policy developments and others being proposed could impact government exclusion and anti-kickback considerations going forward
Please submit the form below to view this resource.